OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex proteins. Optimizing these processes involves fine-tuning various factors, including cell line engineering, media formulation, and bioreactor settings. A key goal is to increase antibody titer while reducing production costs and